查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1872183

酵素免疫分析法（ELISA）：全球市場佔有率和排名、總收入和需求預測（2025-2031 年）

Enzyme-Linked Immunosorbent Assay (ELISA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 133 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球酵素免疫分析法(ELISA) 市場預計在 2024 年達到 17.91 億美元，預計到 2031 年將達到 23.73 億美元，2025 年至 2031 年的複合年成長率為 4.2%。

本報告全面評估了近期關稅調整和國際戰略反制措施對酵素免疫分析法試驗 (ELISA)跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響。

酵素免疫分析法（ELISA）試劑盒是應用最廣泛的酵素免疫分析法技術。酵素免疫分析法（ELISA），也稱為酵素免疫分析法（EIA），是一種主要用於免疫學的生化技術，用於檢測檢體中抗體或抗原的存在。在ELISA試劑盒中，捕獲抗體結合在固相載體上。將含有已知或未知抗原的樣本加入基質或緩衝液中，以最大程度地減少抗原與固相載體的黏附。然後加入酵素標記的抗體進行檢測。酵素免疫分析法（ELISA）是一種基於微孔板的分析技術，它利用抗體來檢測和定量液體樣本中目標分析物的存在。

由於酵素免疫分析法(ELISA) 在診斷、研究和品管領域的廣泛應用，其市場正經歷穩定成長。 ELISA 是一種高靈敏度和高特異性的免疫檢測，用於檢測和定量生物樣本中的蛋白質、荷爾蒙、抗體和病原體。它在感染疾病、自體免疫疾病和癌症生物標記的臨床診斷，以及藥物發現和藥物研發中發揮重要作用。 ELISA 能夠同時處理多個樣本，且具有成本效益高、易於自動化等優點，使其成為全球實驗室的首選方法。

市場成長也受到早期疾病檢測需求不斷成長、免疫診斷技術進步以及生命科學研究投入增加的推動。該技術也擴大應用於就地檢驗和高通量篩檢，從而提升了效用。然而，交叉反應風險、對熟練人員的需求以及來自PCR和次世代定序等先進分子診斷工具的競爭等挑戰，可能會限制其在某些領域的廣泛應用。儘管存在這些障礙，但檢測方法和檢測系統的持續創新使ELISA在臨床和研究領域都保持了其作為基礎技術的地位。

本報告旨在對全球酵素免疫分析法試驗 (ELISA) 市場按地區/國家、類型和應用進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

酵素免疫分析法(ELISA) 市場規模、估算和預測以銷售（千）和收入（百萬美元）為單位呈現，基準年為 2024 年，並包含 2020 年至 2031 年的歷史數據和預測數據。定量和定性分析相結合，有助於讀者制定業務/成長策略、評估市場競爭、分析公司在當前市場中的地位，並為酵素免疫分析法(ELISA) 做出明智的業務決策。

市場區隔

公司

  • Thermo Fisher Scientific
  • Enzo Life Sciences
  • BioLegend
  • Merck
  • Bio-Techne
  • BD Biosciences
  • Bio-Rad Laboratorie
  • Aviva Systems Biology
  • Repligen
  • Lifespan Biosciences
  • PerkinElmer
  • BioVision
  • Innovative Research
  • Biomatik
  • Shanghai Kehua Bio-Engineering
  • Biomerieux

按類型分類的細分市場

  • 間接ELISA
  • 夾心ELISA
  • 競爭性ELISA
  • 其他

應用領域

  • 實驗室
  • 檢查機構
  • 醫院
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Enzyme-Linked Immunosorbent Assay (ELISA) was estimated to be worth US$ 1791 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Enzyme-Linked Immunosorbent Assay (ELISA) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

ELISA Kit (enzyme-linked immunosorbent assay) is the most widely used technology in enzyme immunoassay technology. Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. ELISA kit involve attachment of a capture antibody to a solid phase support. Samples containing known or unknown antigen are then added in a matrix or buffer that will minimize attachment to the solid phase. An enzyme-labeled antibody is then added for detection. Enzyme-linked immunosorbent assay (ELISA) is an analytical, plate-based technique to detect and quantify the presence of an target analyte in a liquid sample using antibodies.

The Enzyme-Linked Immunosorbent Assay (ELISA) market is growing steadily, driven by its wide application in diagnostics, research, and quality control. ELISA is a highly sensitive and specific immunoassay used to detect and quantify proteins, hormones, antibodies, and pathogens in biological samples. It plays a critical role in clinical diagnostics for infectious diseases, autoimmune disorders, and cancer biomarkers, as well as in drug development and pharmaceutical research. Its ability to process multiple samples simultaneously, coupled with cost-effectiveness and compatibility with automation, makes ELISA a preferred choice for laboratories worldwide.

Market growth is further fueled by the increasing demand for early disease detection, advancements in immunodiagnostic technologies, and rising investment in life sciences research. The technique is also being adapted for use in point-of-care testing and high-throughput screening, improving its utility across healthcare and biotechnology sectors. However, challenges such as the risk of cross-reactivity, the need for skilled personnel, and competition from advanced molecular diagnostic tools like PCR and next-generation sequencing can limit adoption in certain areas. Despite these hurdles, ongoing innovations in assay formats and detection systems ensure that ELISA remains a cornerstone technology in both clinical and research settings.

This report aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (ELISA), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enzyme-Linked Immunosorbent Assay (ELISA) by region & country, by Type, and by Application.

The Enzyme-Linked Immunosorbent Assay (ELISA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (ELISA).

Market Segmentation

By Company

  • Thermo Fisher Scientific
  • Enzo Life Sciences
  • BioLegend
  • Merck
  • Bio-Techne
  • BD Biosciences
  • Bio-Rad Laboratorie
  • Aviva Systems Biology
  • Repligen
  • Lifespan Biosciences
  • PerkinElmer
  • BioVision
  • Innovative Research
  • Biomatik
  • Shanghai Kehua Bio-Engineering
  • Biomerieux

Segment by Type

  • Indirect ELISA
  • Sandwich ELISA
  • Competitive ELISA
  • Others

Segment by Application

  • Laboratory
  • Testing Institutions
  • Hospital
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Enzyme-Linked Immunosorbent Assay (ELISA) Product Introduction
  • 1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast
    • 1.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2020-2031)
    • 1.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume (2020-2031)
    • 1.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Price (2020-2031)
  • 1.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market Trends & Drivers
    • 1.3.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends
    • 1.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers & Opportunity
    • 1.3.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market Challenges
    • 1.3.4 Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Players Revenue Ranking (2024)
  • 2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Company (2020-2025)
  • 2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Players Sales Volume Ranking (2024)
  • 2.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Company Players (2020-2025)
  • 2.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Enzyme-Linked Immunosorbent Assay (ELISA) Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Enzyme-Linked Immunosorbent Assay (ELISA) Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Enzyme-Linked Immunosorbent Assay (ELISA)
  • 2.9 Enzyme-Linked Immunosorbent Assay (ELISA) Market Competitive Analysis
    • 2.9.1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Enzyme-Linked Immunosorbent Assay (ELISA) Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Indirect ELISA
    • 3.1.2 Sandwich ELISA
    • 3.1.3 Competitive ELISA
    • 3.1.4 Others
  • 3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type
    • 3.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Type (2020-2031)
    • 3.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Type
    • 3.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Laboratory
    • 4.1.2 Testing Institutions
    • 4.1.3 Hospital
    • 4.1.4 Others
  • 4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application
    • 4.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Application (2020-2031)
    • 4.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Application
    • 4.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region
    • 5.1.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2020-2025)
    • 5.1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2026-2031)
    • 5.1.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (%), (2020-2031)
  • 5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region
    • 5.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (2020-2025)
    • 5.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (2026-2031)
    • 5.2.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 5.4.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 5.5.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 5.7.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 6.3.2 United States Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 6.4.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 6.5.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 6.6.2 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 6.7.2 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020-2031
    • 6.9.2 India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Thermo Fisher Scientific
    • 7.1.1 Thermo Fisher Scientific Company Information
    • 7.1.2 Thermo Fisher Scientific Introduction and Business Overview
    • 7.1.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.1.5 Thermo Fisher Scientific Recent Development
  • 7.2 Enzo Life Sciences
    • 7.2.1 Enzo Life Sciences Company Information
    • 7.2.2 Enzo Life Sciences Introduction and Business Overview
    • 7.2.3 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.2.5 Enzo Life Sciences Recent Development
  • 7.3 BioLegend
    • 7.3.1 BioLegend Company Information
    • 7.3.2 BioLegend Introduction and Business Overview
    • 7.3.3 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.3.5 BioLegend Recent Development
  • 7.4 Merck
    • 7.4.1 Merck Company Information
    • 7.4.2 Merck Introduction and Business Overview
    • 7.4.3 Merck Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Merck Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.4.5 Merck Recent Development
  • 7.5 Bio-Techne
    • 7.5.1 Bio-Techne Company Information
    • 7.5.2 Bio-Techne Introduction and Business Overview
    • 7.5.3 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.5.5 Bio-Techne Recent Development
  • 7.6 BD Biosciences
    • 7.6.1 BD Biosciences Company Information
    • 7.6.2 BD Biosciences Introduction and Business Overview
    • 7.6.3 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.6.5 BD Biosciences Recent Development
  • 7.7 Bio-Rad Laboratorie
    • 7.7.1 Bio-Rad Laboratorie Company Information
    • 7.7.2 Bio-Rad Laboratorie Introduction and Business Overview
    • 7.7.3 Bio-Rad Laboratorie Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Bio-Rad Laboratorie Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.7.5 Bio-Rad Laboratorie Recent Development
  • 7.8 Aviva Systems Biology
    • 7.8.1 Aviva Systems Biology Company Information
    • 7.8.2 Aviva Systems Biology Introduction and Business Overview
    • 7.8.3 Aviva Systems Biology Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Aviva Systems Biology Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.8.5 Aviva Systems Biology Recent Development
  • 7.9 Repligen
    • 7.9.1 Repligen Company Information
    • 7.9.2 Repligen Introduction and Business Overview
    • 7.9.3 Repligen Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Repligen Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.9.5 Repligen Recent Development
  • 7.10 Lifespan Biosciences
    • 7.10.1 Lifespan Biosciences Company Information
    • 7.10.2 Lifespan Biosciences Introduction and Business Overview
    • 7.10.3 Lifespan Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Lifespan Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.10.5 Lifespan Biosciences Recent Development
  • 7.11 PerkinElmer
    • 7.11.1 PerkinElmer Company Information
    • 7.11.2 PerkinElmer Introduction and Business Overview
    • 7.11.3 PerkinElmer Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 PerkinElmer Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.11.5 PerkinElmer Recent Development
  • 7.12 BioVision
    • 7.12.1 BioVision Company Information
    • 7.12.2 BioVision Introduction and Business Overview
    • 7.12.3 BioVision Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 BioVision Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.12.5 BioVision Recent Development
  • 7.13 Innovative Research
    • 7.13.1 Innovative Research Company Information
    • 7.13.2 Innovative Research Introduction and Business Overview
    • 7.13.3 Innovative Research Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Innovative Research Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.13.5 Innovative Research Recent Development
  • 7.14 Biomatik
    • 7.14.1 Biomatik Company Information
    • 7.14.2 Biomatik Introduction and Business Overview
    • 7.14.3 Biomatik Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Biomatik Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.14.5 Biomatik Recent Development
  • 7.15 Shanghai Kehua Bio-Engineering
    • 7.15.1 Shanghai Kehua Bio-Engineering Company Information
    • 7.15.2 Shanghai Kehua Bio-Engineering Introduction and Business Overview
    • 7.15.3 Shanghai Kehua Bio-Engineering Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Shanghai Kehua Bio-Engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.15.5 Shanghai Kehua Bio-Engineering Recent Development
  • 7.16 Biomerieux
    • 7.16.1 Biomerieux Company Information
    • 7.16.2 Biomerieux Introduction and Business Overview
    • 7.16.3 Biomerieux Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Biomerieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
    • 7.16.5 Biomerieux Recent Development

8 Industry Chain Analysis

  • 8.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industrial Chain
  • 8.2 Enzyme-Linked Immunosorbent Assay (ELISA) Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Enzyme-Linked Immunosorbent Assay (ELISA) Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Enzyme-Linked Immunosorbent Assay (ELISA) Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Enzyme-Linked Immunosorbent Assay (ELISA) Market Trends
  • Table 2. Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers & Opportunity
  • Table 3. Enzyme-Linked Immunosorbent Assay (ELISA) Market Challenges
  • Table 4. Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
  • Table 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Company (2020-2025)
  • Table 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Enzyme-Linked Immunosorbent Assay (ELISA) Price by Company (2020-2025) & (USD/Unit)
  • Table 10. Key Manufacturers Enzyme-Linked Immunosorbent Assay (ELISA) Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Enzyme-Linked Immunosorbent Assay (ELISA) Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Enzyme-Linked Immunosorbent Assay (ELISA)
  • Table 13. Global Enzyme-Linked Immunosorbent Assay (ELISA) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Enzyme-Linked Immunosorbent Assay (ELISA) Price by Type (2020-2025) & (USD/Unit)
  • Table 27. Global Enzyme-Linked Immunosorbent Assay (ELISA) Price by Type (2026-2031) & (USD/Unit)
  • Table 28. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Enzyme-Linked Immunosorbent Assay (ELISA) Price by Application (2020-2025) & (USD/Unit)
  • Table 39. Global Enzyme-Linked Immunosorbent Assay (ELISA) Price by Application (2026-2031) & (USD/Unit)
  • Table 40. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Region (2020-2025) & (USD/Unit)
  • Table 51. Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Region (2026-2031) & (USD/Unit)
  • Table 52. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume, (2026-2031) & (K Units)
  • Table 57. Thermo Fisher Scientific Company Information
  • Table 58. Thermo Fisher Scientific Introduction and Business Overview
  • Table 59. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 60. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 61. Thermo Fisher Scientific Recent Development
  • Table 62. Enzo Life Sciences Company Information
  • Table 63. Enzo Life Sciences Introduction and Business Overview
  • Table 64. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 65. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 66. Enzo Life Sciences Recent Development
  • Table 67. BioLegend Company Information
  • Table 68. BioLegend Introduction and Business Overview
  • Table 69. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 70. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 71. BioLegend Recent Development
  • Table 72. Merck Company Information
  • Table 73. Merck Introduction and Business Overview
  • Table 74. Merck Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 75. Merck Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 76. Merck Recent Development
  • Table 77. Bio-Techne Company Information
  • Table 78. Bio-Techne Introduction and Business Overview
  • Table 79. Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 80. Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 81. Bio-Techne Recent Development
  • Table 82. BD Biosciences Company Information
  • Table 83. BD Biosciences Introduction and Business Overview
  • Table 84. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 85. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 86. BD Biosciences Recent Development
  • Table 87. Bio-Rad Laboratorie Company Information
  • Table 88. Bio-Rad Laboratorie Introduction and Business Overview
  • Table 89. Bio-Rad Laboratorie Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 90. Bio-Rad Laboratorie Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 91. Bio-Rad Laboratorie Recent Development
  • Table 92. Aviva Systems Biology Company Information
  • Table 93. Aviva Systems Biology Introduction and Business Overview
  • Table 94. Aviva Systems Biology Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 95. Aviva Systems Biology Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 96. Aviva Systems Biology Recent Development
  • Table 97. Repligen Company Information
  • Table 98. Repligen Introduction and Business Overview
  • Table 99. Repligen Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 100. Repligen Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 101. Repligen Recent Development
  • Table 102. Lifespan Biosciences Company Information
  • Table 103. Lifespan Biosciences Introduction and Business Overview
  • Table 104. Lifespan Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 105. Lifespan Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 106. Lifespan Biosciences Recent Development
  • Table 107. PerkinElmer Company Information
  • Table 108. PerkinElmer Introduction and Business Overview
  • Table 109. PerkinElmer Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 110. PerkinElmer Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 111. PerkinElmer Recent Development
  • Table 112. BioVision Company Information
  • Table 113. BioVision Introduction and Business Overview
  • Table 114. BioVision Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 115. BioVision Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 116. BioVision Recent Development
  • Table 117. Innovative Research Company Information
  • Table 118. Innovative Research Introduction and Business Overview
  • Table 119. Innovative Research Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 120. Innovative Research Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 121. Innovative Research Recent Development
  • Table 122. Biomatik Company Information
  • Table 123. Biomatik Introduction and Business Overview
  • Table 124. Biomatik Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 125. Biomatik Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 126. Biomatik Recent Development
  • Table 127. Shanghai Kehua Bio-Engineering Company Information
  • Table 128. Shanghai Kehua Bio-Engineering Introduction and Business Overview
  • Table 129. Shanghai Kehua Bio-Engineering Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 130. Shanghai Kehua Bio-Engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 131. Shanghai Kehua Bio-Engineering Recent Development
  • Table 132. Biomerieux Company Information
  • Table 133. Biomerieux Introduction and Business Overview
  • Table 134. Biomerieux Enzyme-Linked Immunosorbent Assay (ELISA) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 135. Biomerieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Offerings
  • Table 136. Biomerieux Recent Development
  • Table 137. Key Raw Materials Lists
  • Table 138. Raw Materials Key Suppliers Lists
  • Table 139. Enzyme-Linked Immunosorbent Assay (ELISA) Downstream Customers
  • Table 140. Enzyme-Linked Immunosorbent Assay (ELISA) Distributors List
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Enzyme-Linked Immunosorbent Assay (ELISA) Product Picture
  • Figure 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Price (2020-2031) & (USD/Unit)
  • Figure 6. Enzyme-Linked Immunosorbent Assay (ELISA) Report Years Considered
  • Figure 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Enzyme-Linked Immunosorbent Assay (ELISA) Revenue in 2024
  • Figure 10. Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Indirect ELISA Picture
  • Figure 12. Sandwich ELISA Picture
  • Figure 13. Competitive ELISA Picture
  • Figure 14. Others Picture
  • Figure 15. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Market Share by Type, 2024 & 2031
  • Figure 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 18. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume Market Share by Type, 2024 & 2031
  • Figure 19. Global Enzyme-Linked Immunosorbent Assay (ELISA) Price by Type (2020-2031) & (USD/Unit)
  • Figure 20. Product Picture of Laboratory
  • Figure 21. Product Picture of Testing Institutions
  • Figure 22. Product Picture of Hospital
  • Figure 23. Product Picture of Others
  • Figure 24. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 25. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value Market Share by Application, 2024 & 2031
  • Figure 26. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 27. Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume Market Share by Application, 2024 & 2031
  • Figure 28. Global Enzyme-Linked Immunosorbent Assay (ELISA) Price by Application (2020-2031) & (USD/Unit)
  • Figure 29. North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (2020-2031) & (US$ Million)
  • Figure 30. North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Region (%), 2024 VS 2031
  • Figure 35. South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Country (%), 2024 VS 2031
  • Figure 39. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value (%), (2020-2031)
  • Figure 40. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (ELISA) Sales Volume (%), (2020-2031)
  • Figure 41. United States Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. United States Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • Figure 43. United States Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (%), 2024 VS 2031
  • Figure 44. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (%), 2024 VS 2031
  • Figure 47. China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • Figure 49. China Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (%), 2024 VS 2031
  • Figure 50. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • Figure 52. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (%), 2024 VS 2031
  • Figure 53. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • Figure 55. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (%), 2024 VS 2031
  • Figure 56. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • Figure 58. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (%), 2024 VS 2031
  • Figure 59. India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value, (2020-2031) & (US$ Million)
  • Figure 60. India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Type (%), 2024 VS 2031
  • Figure 61. India Enzyme-Linked Immunosorbent Assay (ELISA) Sales Value by Application (%), 2024 VS 2031
  • Figure 62. Enzyme-Linked Immunosorbent Assay (ELISA) Industrial Chain
  • Figure 63. Enzyme-Linked Immunosorbent Assay (ELISA) Manufacturing Cost Structure
  • Figure 64. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 65. Bottom-up and Top-down Approaches for This Report
  • Figure 66. Data Triangulation
  • Figure 67. Key Executives Interviewed